Cite
HARVARD Citation
Smith, M. et al. (2022). Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre Cohort. Journal of the Canadian Association of Gastroenterology. 5 (1), pp. 39-47. [Online].